Pauline Kim

21.9k total citations
8 papers, 26 citations indexed

About

Pauline Kim is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Pauline Kim has authored 8 papers receiving a total of 26 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pulmonary and Respiratory Medicine, 3 papers in Molecular Biology and 3 papers in Oncology. Recurrent topics in Pauline Kim's work include Lung Cancer Treatments and Mutations (4 papers), Cancer Genomics and Diagnostics (3 papers) and Lung Cancer Diagnosis and Treatment (2 papers). Pauline Kim is often cited by papers focused on Lung Cancer Treatments and Mutations (4 papers), Cancer Genomics and Diagnostics (3 papers) and Lung Cancer Diagnosis and Treatment (2 papers). Pauline Kim collaborates with scholars based in United States, South Korea and Lebanon. Pauline Kim's co-authors include Ravi Salgia, Isa Mambetsariev, Jianjun Chen, Priya Vishnubhotla, Patrick J. Kiel, Vivek Subbiah, Bihong T. Chen, Dong M. Shin, Stephen B. Gruber and Prakash Kulkarni and has published in prestigious journals such as SHILAP Revista de lepidopterología, Head & Neck and Journal of Clinical Medicine.

In The Last Decade

Pauline Kim

7 papers receiving 25 citations

Peers

Pauline Kim

MB

PRM

ONCOL

CR

RNMI

Julia E. Rudolph United States

Dana R. Valley United States

Guowu Wu China

Peter Steinwald United States

Janet Files United States

Gloryanne Aidoo-Micah United Kingdom

Pablo Sáez Scherbovsky Argentina

Heidi Dowst United States

Jes Chauviere Lee United States

X. L. Guo China

Julia E. Rudolph United States

Pauline Kim

10 ×0.9

MB

7 ×0.6

PRM

6 ×1.0

ONCOL

7 ×1.2

CR

3 ×1.0

RNMI

Citations per year, relative to Pauline Kim Pauline Kim (= 1×) peers Julia E. Rudolph

Countries citing papers authored by Pauline Kim

Since Specialization

Citations

This map shows the geographic impact of Pauline Kim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pauline Kim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pauline Kim more than expected).

Fields of papers citing papers by Pauline Kim

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pauline Kim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pauline Kim. The network helps show where Pauline Kim may publish in the future.

Co-authorship network of co-authors of Pauline Kim

This figure shows the co-authorship network connecting the top 25 collaborators of Pauline Kim. A scholar is included among the top collaborators of Pauline Kim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pauline Kim. Pauline Kim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Mambetsariev, Isa, et al.. (2025). Novel LZTR1 germline mutation as a mechanism of resistance to osimertinib in EGFR-mutated lung adenocarcinoma: a case report. Translational Lung Cancer Research. 14(2). 625–630. 2 indexed citations

2.

Kim, Pauline, Nabil F. Saba, Yuan Liu, et al.. (2025). Prospective Pilot Study of Second Primary Tumor Prevention With Erlotinib and Celecoxib in Early‐Stage Squamous Cell Carcinoma of the Head and Neck: Long‐Term Follow‐Up. Head & Neck. 47(9). 2594–2602. 1 indexed citations

3.

Han, Sang Hoon, Ramireddy Bommireddy, Pauline Kim, Periasamy Selvaraj, & Dong M. Shin. (2024). Chemoprevention of Head and Neck Cancer: A Review of Current Approaches and Future Perspectives. Cancer Prevention Research. 17(10). 443–455. 2 indexed citations

4.

Malhotra, Jyoti, Ramya Muddasani, Isa Mambetsariev, et al.. (2024). Clinical Utility of a Circulating Tumor Cell–Based Cerebrospinal Fluid Assay in the Diagnosis and Molecular Analysis of Leptomeningeal Disease in Patients With Advanced Non–Small Cell Lung Cancer. JCO Precision Oncology. 8(8). e2400373–e2400373. 2 indexed citations

5.

Moniz‐Garcia, Diogo, Isa Mambetsariev, Daniel Schmolze, et al.. (2023). Complete response to chemoimmunotherapy with bevacizumab in synchronous multiple primary cancers: pulmonary adenocarcinoma and sarcomatoid carcinoma. Molecular Case Studies. 9(2). a006262–a006262. 1 indexed citations

6.

Mambetsariev, Isa, Stephen B. Gruber, Pauline Kim, et al.. (2023). Clinical Network Systems Biology: Traversing the Cancer Multiverse. Journal of Clinical Medicine. 12(13). 4535–4535. 5 indexed citations

7.

Wang, Joshua, Isa Mambetsariev, Pauline Kim, et al.. (2023). Selpercatinib and Pralsetinib Induced Chylous Ascites in RET-Rearranged Lung Adenocarcinoma: A Case Series. Clinical Lung Cancer. 24(7). 666–671. 9 indexed citations

8.

Kim, Pauline, et al.. (2020). Precision Genomic Practice in Oncology: Pharmacist Role and Experience in an Ambulatory Care Clinic. SHILAP Revista de lepidopterología. 8(1). 32–32. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact